Global Immunohistochemistry Market Insights Forecasts to 2033

• The Global Immunohistochemistry Market Size was Valued at USD 2.60 Billion in 2023
• The Market Size is Growing at a CAGR of 6.41% from 2023 to 2033
• The Worldwide Immunohistochemistry Market Size is Expected to Reach USD 4.84 Billion by 2033
• Asia Pacific is Expected to Grow the fastest during the forecast period.

The Global Immunohistochemistry Market Size is Anticipated to Exceed USD 4.84 Billion by 2033, Growing at a CAGR of 6.41% from 2023 to 2033.

Market Overview

Immunohistochemistry (IHC) is an antibody-based laboratory technique for detecting specific antigens (markers) in tissue samples. Antibodies are typically coupled to enzymes or fluorescent dyes. After the antibodies bind to the antigen in the tissue sample, the enzyme or dye is triggered, allowing the antigen to be seen under a microscope. Immunohistochemistry is used to diagnose disorders like cancer. It might also be used to assist in distinguishing between different forms of cancer. Immunohistochemistry (IHC) is a laboratory technique used to visualize the presence and localization of specific proteins or antigens in tissue sections. The immunohistochemistry technique combines histological, immunological, and biochemical techniques to identify and visualize specific cellular components within tissue samples. The market for immunohistochemistry is developing as more products are allowed for use, there is a greater emphasis on drug monitoring, there are improved chances of identifying various diseases, there are technological developments, and the public is more aware of new diagnostics equipment. The immunohistochemistry market is expected to grow slowly because of the limited specificity of IHC techniques and expensive setup costs. To properly manage an illness, malignant growths must be recognized precisely and quickly.

Report Coverage

This research report categorizes the market for the global immunohistochemistry market based on various segments and regions forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the global immunohistochemistry market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the global immunohistochemistry market.

Driving Factors

The global immunohistochemistry market is experiencing significant growth driven by several key factors. Firstly, the increasing incidence of chronic diseases, such as cancer and cardiovascular disorders, fuels the demand for accurate diagnostic techniques like immunohistochemistry. Technological advancements, including automated systems and multiplex assays, enhance the efficiency and sensitivity of IHC, attracting healthcare providers and researchers. Additionally, the aging population, rising healthcare expenditure, and government initiatives promoting research further contribute to market expansion. Moreover, the shift towards personalized medicine and growing awareness about early disease detection bolster the adoption of immunohistochemistry for precise diagnosis and targeted therapy. These factors collectively shape a promising outlook for the global immunohistochemistry market, driving its growth and evolution.

Restraining Factors

The growth of the global immunohistochemistry market can be restrained by several factors. High costs associated with equipment and reagents, coupled with limited reimbursement policies, might impede widespread adoption, particularly in resource-limited settings. The complexity of interpretation and regulatory challenges further add hurdles to implementation. Additionally, emerging alternative diagnostic technologies and accessibility issues in developing regions pose competition and limit market expansion. Although immunohistochemistry is commonly used, there are other modern technologies available, such as RNA sequencing, Next Generation Sequence, Fluorescence In Situ Hybridization (FISH), and others that hinder the growth of the immunohistochemistry market.

Market Segmentation

The global immunohistochemistry market share is classified into product, application, and end-user.

• The antibodies segment dominates the market with the largest market share through the forecast period.

Based on the product, the global immunohistochemistry market is categorized into antibodies, reagents, equipment, and kits. Among these, the antibodies segment dominates the market with the largest market share through the forecast period. The high market share of the antibody product sector can be ascribed to advances in antibody discovery and production techniques, which have greatly improved product quality, sensitivity, and specificity for IHC applications. Antibodies are highly specific, allowing them to detect a broad range of antigens with high sensitivity. Their advancement has enabled the discovery of previously unknown biomarkers, paving the way for discoveries. The continuous focus on generating novel monoclonal and polyclonal antibodies against emerging targets will benefit diagnostics and research. Hybridoma technology and recombinant procedures produce antibodies that have higher affinity and specificity.

• The diagnostics segment is anticipated to hold the largest market share through the forecast period.

Based on the application, the global immunohistochemistry market is categorized into diagnostics, research, forensics, and others. Among these, the diagnostics segment is anticipated to grow at the fastest CAGR growth through the forecast period. Due to several factors, the rising prevalence of chronic diseases, such as cancers and cardiovascular conditions, necessitates precise diagnostic tools like IHC. Technological advancements in IHC improve diagnostic accuracy and efficiency, supporting this growth. The increasing emphasis on personalized medicine, which relies on specific biomarker identification, further drives demand for IHC diagnostics. Additionally, the aging global population boosts the need for diagnostic services for age-related diseases. Increased government and private funding, along with regulatory approvals for new IHC tests, expand the market's capabilities. Lastly, enhanced awareness and public health initiatives promoting early disease detection and screening contribute to the rapid growth of the diagnostics segment.

• The diagnostics laboratories segment accounted for the highest market share through the forecast period.

Based on the end-user, the global immunohistochemistry market is categorized into hospitals, diagnostics laboratories, academic, research institutes, and others. Among these, the diagnostics laboratories segment accounted for the highest market share through the forecast period. Laboratories have large staining platforms and boarded anatomical pathologists for expert sign-out. They perform big test volumes economically by automating and improving efficiency. In addition to local hospital capabilities, reference labs provide specialized multiplex testing. IHC is used in research and academic settings, although its primary focus is elsewhere. Cost containment and a lack of reimbursement limit hospital adoption. Diagnostic labs, on the other hand, rely heavily on IHC revenue from contracts with pathology organizations and payers. Strong reference laboratory networks provide worldwide reach. Robust infrastructure and analytics capabilities enable labs to create novel multiplex tests. The diagnostics laboratory's specialization and economies of scale foster consolidation, maintaining market dominance.

Regional Segment Analysis of the Global Immunohistochemistry Market

• North America (U.S., Canada, Mexico) 
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America) 
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

North America is anticipated to hold the largest share of the global immunohistochemistry market over the predicted timeframe.

North America is projected to hold the largest share of the global immunohistochemistry market over the forecast period. The leading position of North America in the global immunohistochemistry market is largely due to the presence of top life sciences companies and research organizations in the U.S. and Canada. Several biopharmaceutical companies have headquarters in the region and invest extensively in R&D for drug development and diagnostic solutions. Immunohistochemistry techniques have led to broad adoption in academic and industrial facilities. Furthermore, North America has a well-developed healthcare system and wider access to innovative diagnostic methods. This has increased the demand for immunohistochemistry in the region due to hospital-based clinical applications.

Asia Pacific is expected to grow at the fastest CAGR growth of the global immunohistochemistry market during the forecast period. Several key driving factors that enhance the growth of the immunohistochemistry market in the region include the rising prevalence of chronic diseases, increasing healthcare expenditure, expanding biotechnology and pharmaceutical industries, technological advancements, high disposable income, increasing demand for quality medical care, government investment in research, growing awareness of early diagnosis, supportive government initiatives, and an aging population.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the global immunohistochemistry market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• F. Hoffmann-LA-Roche AG
• Bio care Medical LLC
• Merck KGAA
• Thermo Fisher Scientific
• Eagle Bioscience Inc
• Bio-Genex Laboratories
• Rockland Immunochemicals Inc.
• Bio-Techne Corporation
• Danaher Corporation
• Bio-Rad Laboratories Inc.
• Bio SB Inc.
• Histo-Line Laboratories
• Diagnostic Biosystems Inc.
• Miltenyi Biotech
• Enzo Biochem Inc.
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting And Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Recent Developments

• In April 2024, the FDA approval for trastuzumab deruxtecan-nxki (Enhertu, AstraZeneca, and Daiichi Sankyo, Inc.) for adult patients with unresectable or metastatic HER2-positive (IHC 3+) solid tumors who have received prior systemic treatment and have no satisfactory alternative treatment options.

• In March 2024, the FDA approved mirvetuximab soravtansine-gynx for adult patients with platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer who have received 1 to 3 prior systemic treatments.

• In March 2023, Paige and Mindpeak announced the integration of artificial intelligence (AI) algorithms for immunohistochemical biomarker quantification into the company's platform to provide real-time quantitative results for routine IHC biomarkers in lung and breast cancer.

Market Segment

This study forecasts revenue at global, regional, and country levels from 2023 to 2033. Spherical Insights has segmented the global immunohistochemistry market based on the below-mentioned segments: 

Global Immunohistochemistry Market, By Product

• Antibodies
• Reagents
• Equipment
• Kits

Global Immunohistochemistry Market, By Application

• Diagnostics
• Research
• Forensic
• Others

Global Immunohistochemistry Market, By End-User

• Hospitals
• Diagnostics Laboratories
• Academic
• Research Institutes
• Others

Global Immunohistochemistry Market, By Regional Analysis

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa